Naturbeads has received €4.1 million in EU funding to develop biodegradable microbeads aimed at reducing microplastic pollution.
Browsing: Science
Habitasse platea dictumst vestibulum rhoncus est pellentesque elit. Enim diam vulputate ut pharetra sit amet aliquam id.
Epoch Biodesign reveals a new biorecycling facility in London, following a successful €10.3 million funding round to advance sustainable nylon production.
ATMOS has raised €25.7 million to launch its ambitious plan for a space cargo highway, revolutionizing space logistics.
STORM Therapeutics introduces groundbreaking RNA modification techniques to advance cancer treatment options.
ONWARD Medical is innovating neurotechnology to restore movement for spinal cord injury patients.
STORM Therapeutics raises $56 million for Phase 2 trials of STC-15, the first METTL3 inhibitor targeting rare sarcoma cancers.
BioLamina, a Stockholm-based BioTech firm, has secured a €20 million financing to advance its matrix biology and cell culture technologies.
CamGraPhIC receives €211 million funding approval from the European Commission to advance 2D photonics research.
EVANIUM has successfully raised €2.2 million to enhance its OPTISOLV® drug delivery technology.
A US science and technology council report outlines how Washington is quietly rewriting its industrial strategy to compete in chips, clean energy and critical tech.